1-20 of 24
Sort by
News

February 2024 Data Stream

Free
Published: 2024
Abstract
February 2024
View News titled, February 2024 Data Stream
News

Study Identifies Drugs With Greatest Association With Drug-Induced Hemolytic Anemia

Free
Ruth Jessen Hickman, MD
Published: 2024
Abstract
February 2024
View News titled, Study Identifies Drugs With Greatest Association With Drug-Induced Hemolytic Anemia
News

IKZF1 Alterations an Independent Marker of AML Risk

Free
Leah Lawrence
Published: 2024
Abstract
February 2024
View News titled, IKZF1 Alterations an Independent Marker of AML Risk
News

Study Examines Quality and Potential Use of Real-World Data in DLBCL

Free
Katie Robinson
Published: 2024
Abstract
February 2024
View News titled, Study Examines Quality and Potential Use of Real-World Data in DLBCL
News

Study Proposes Recommendations for Infections During Teclistamab Treatment of R/R MM

Free
Katie Robinson
Published: 2024
Abstract
February 2024
View News titled, Study Proposes Recommendations for Infections During Teclistamab Treatment of R/R MM
News

Etranacogene Dezaparvovec Bests Extended Half-Life Factor IX Products in Hemophilia B Prophylaxis

Free
Katie Robinson
Published: 2024
Abstract
February 2024
View News titled, Etranacogene Dezaparvovec Bests Extended Half-Life Factor IX Products in Hemophilia B Prophylaxis
News

The ASH Guide to Advocacy: How to Make an Impact in Hematology

Free
Published: 2024
Abstract
February 2024
View News titled, The ASH Guide to Advocacy: How to Make an Impact in Hematology
News

Should Iron Deficiency Be Treated With Oral or IV Iron?

Free
Emma Yasinski
Published: 2024
Abstract
February 2024
View News titled, Should Iron Deficiency Be Treated With Oral or IV Iron?
News

How I Treat Erythropoietic Protoporphyria and X-Linked Protoporphyria

Free
Published: 2024
Abstract
February 2024
View News titled, How I Treat Erythropoietic Protoporphyria and X-Linked Protoporphyria
News

Navigating the Intersection of Medicine and Policy: A Purpose-Driven Journey of Impact

Free
Published: 2024
Abstract
February 2024
View News titled, Navigating the Intersection of Medicine and Policy: A Purpose-Driven Journey of Impact
News

Metrics by Which We Measure Quality: From Questions to Psychological Safety

Free
Published: 2024
Abstract
February 2024
View News titled, Metrics by Which We Measure Quality: From Questions to Psychological Safety
News

Would you proceed with a 7/8 matched unrelated donor alloHCT in a patient with severe acquired aplastic anemia?

Free
Published: 2024
Abstract
February 2024
View News titled, Would you proceed with a 7/8 matched unrelated donor alloHCT in a patient with severe acquired aplastic anemia?
News

You Make the Call: Would you proceed with a 7/8 matched unrelated donor alloHCT in a patient with severe acquired aplastic anemia?

Free
Published: 2024
Abstract
February 2024
View News titled, You Make the Call: Would you proceed with a 7/8 matched unrelated donor alloHCT in a patient with severe acquired aplastic anemia?
News

Leading Breakthroughs in Blood Cancer Care: E. Anders “Andy” Kolb, MD

Free
Published: 2024
Abstract
February 2024 In this issue, E. Anders (Andy) Kolb, MD, talks about serving families with blood cancers, attending the Dare to Dream Summit, and connecting with staff, volunteers, and donors in his role as president and CEO of the Leukemia & Lymphoma Society.
View News titled, Leading Breakthroughs in Blood Cancer Care: E. Anders “Andy” Kolb, MD
News

Trials and Tribulations: Running Clinical Trials in LMICs Can Be a Challenge

Free
Mary Ellen Schneider
Published: 2024
Abstract
February 2024
View News titled, Trials and Tribulations: Running Clinical Trials in LMICs Can Be a Challenge
News

When the Hoofbeats Are From Zebras

Free
Emma Yasinski
Published: 2024
Abstract
February 2024 Diagnosing rare diseases requires physicians to think broadly, collaborate with specialists, and be persistent.
View News titled, When the Hoofbeats Are From Zebras
News

Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%

Free
Lara C. Pullen, PhD
Published: 2024
Abstract
February 2024
View News titled, Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%
News

Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure

Free
Lara C. Pullen, PhD
Published: 2024
Abstract
February 2024
View News titled, Anti-PF4 Immunothrombosis Absent Proximate Heparin or Adenovirus Vector Vaccine Exposure
News

Time-Limited Ibrutinib, CD19-Directed CAR-T Combo Shows Efficacy for Poor-Risk, R/R Mantle Cell Lymphoma

Free
Khylia Marshall
Published: 2024
Abstract
February 2024
View News titled, Time-Limited Ibrutinib, CD19-Directed CAR-T Combo Shows Efficacy for Poor-Risk, R/R Mantle Cell Lymphoma
News

Inotuzumab as a Bridging Therapy to Eradicate MRD Improves OS in Patients With ALL

Free
Khylia Marshall
Published: 2024
Abstract
February 2024
View News titled, Inotuzumab as a Bridging Therapy to Eradicate MRD Improves OS in Patients With ALL